Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition

R Humphries, AM Bobenchik, JA Hindler… - Journal of clinical …, 2021 - Am Soc Microbiol
ABSTRACT The Clinical and Laboratory Standards Institute (CLSI) Subcommittee on
Antimicrobial Susceptibility Testing (AST) develops and publishes standards and guidelines …

[HTML][HTML] Etiology of community-acquired pneumonia in adults: a systematic review

S Shoar, DM Musher - Pneumonia, 2020 - Springer
Background The etiology of community-acquired pneumonia (CAP) has evolved since the
beginning of the antibiotic era. Recent guidelines encourage immediate empiric antibiotic …

Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases …

JP Metlay, GW Waterer, AC Long… - American journal of …, 2019 - atsjournals.org
Background: This document provides evidence-based clinical practice guidelines on the
management of adult patients with community-acquired pneumonia. Methods: A …

[HTML][HTML] Microwave assisted antibacterial action of Garcinia nanoparticles on Gram-negative bacteria

Y Qiao, Y Xu, X Liu, Y Zheng, B Li, Y Han, Z Li… - Nature …, 2022 - nature.com
Owing to the existence of the outer membrane barrier, most antibacterial agents cannot
penetrate Gram-negative bacteria and are ineffective. Here, we report a general method for …

[HTML][HTML] Burden of community-acquired pneumonia and unmet clinical needs

J Ferreira-Coimbra, C Sarda, J Rello - Advances in therapy, 2020 - Springer
Community-acquired pneumonia (CAP) is the leading cause of death among infectious
diseases and an important health problem, having considerable implications for healthcare …

[HTML][HTML] Ten decadal advances in fungal biology leading towards human well-being

A Mapook, KD Hyde, K Hassan, BM Kemkuignou… - Fungal Diversity, 2022 - Springer
Fungi are an understudied resource possessing huge potential for developing products that
can greatly improve human well-being. In the current paper, we highlight some important …

[HTML][HTML] Antibiotics in the pipeline: a literature review (2017–2020)

JA Al-Tawfiq, H Momattin, AY Al-Ali, K Eljaaly… - Infection, 2022 - Springer
Introduction Antimicrobial resistance (AMR) is an emerging global threat. It increases
mortality and morbidity and strains healthcare systems. Health care professionals can …

[HTML][HTML] Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases …

G Tiseo, G Brigante, DR Giacobbe, AE Maraolo… - International Journal of …, 2022 - Elsevier
Management of patients with infections caused by multidrug-resistant organisms is
challenging and requires a multidisciplinary approach to achieve successful clinical …

[HTML][HTML] Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns

M Assefa - Pneumonia, 2022 - Springer
Bacterial pneumonia is one of the most serious public health issues owing to its medical and
economic costs, which result in increased morbidity and mortality in people of all ages …

An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative …

EN Parker, BN Cain, B Hajian, RJ Ulrich… - ACS Central …, 2022 - ACS Publications
Genomic studies and experiments with permeability-deficient strains have revealed a variety
of biological targets that can be engaged to kill Gram-negative bacteria. However, the …